Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Inventory: 2020-2024

Historic Inventory for Cellebrite DI (CLBT) over the last 5 years, with Dec 2024 value amounting to $8.9 million.

  • Cellebrite DI's Inventory fell 11.07% to $8.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.6 million, marking a year-over-year decrease of 11.07%. This contributed to the annual value of $8.9 million for FY2024, which is 10.07% down from last year.
  • Latest data reveals that Cellebrite DI reported Inventory of $8.9 million as of FY2024, which was down 10.07% from $9.9 million recorded in FY2023.
  • Cellebrite DI's 5-year Inventory high stood at $10.2 million for FY2022, and its period low was $4.8 million during FY2020.
  • For the 3-year period, Cellebrite DI's Inventory averaged around $9.7 million, with its median value being $9.9 million (2023).
  • As far as peak fluctuations go, Cellebrite DI's Inventory soared by 56.29% in 2022, and later declined by 10.07% in 2024.
  • Yearly analysis of 5 years shows Cellebrite DI's Inventory stood at $4.8 million in 2020, then surged by 36.96% to $6.5 million in 2021, then soared by 56.29% to $10.2 million in 2022, then decreased by 2.32% to $9.9 million in 2023, then dropped by 10.07% to $8.9 million in 2024.